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The aimof the current study is to assess the prevalence ofCampylobacter infection in broiler chickens, raised in intensive production
conditions, and to evaluate the antimicrobial susceptibility of recoveredCampylobacter isolates. A total of 590 cloacal swab samples
were taken from 13 broiler chicken flocks in the North East of Tunisia. All samples were tested for the presence of thermophilic
Campylobacter by culture and PCR, targeting the mapA and ceuE genes, respectively. Susceptibility to antimicrobial drugs was
tested against 8 antibiotics. Prevalence of Campylobacter infection, relationship with geographic origins and seasons, antimicrobial
resistance rates and patterns were analyzed. Total prevalence of Campylobacter infection in broiler flocks was in the range of 22.4%,
with a predominance of C. jejuni (68.9%), followed by C. coli (31.1%). Positive association was highlighted between the infection
level and the season (P < 0.001), but no link was emphasized considering the geographic origin. Antimicrobial susceptibility testing
revealed very high resistance rates detected against macrolide, tetracycline, quinolones, and chloramphenicol, ranging from 88.6%
to 100%. Lower resistance prevalence was noticed for 𝛽-lactams (47% and 61.4%) and gentamicin (12.9%). 17 R-type patterns were
observed, and a common pattern was found in 30.3% of isolates.This study provides updates and novel data on the prevalence and
the AMR of broiler campylobacters in Tunisia, revealing the occurrence of high resistance to several antibiotics and emphasizing
the requirement of better surveillance and careful regulation of antimicrobials use.
1. Introduction
Campylobacteriosis is a major food-borne zoonosis with
global distribution [1]. In last decade, the number of human
campylobacteriosis cases has increased in both industri-
alized and developed countries, with 96 million cases of
gastroenteritis and 21 thousand deaths per year, worldwide
[2–4]. In fact, diarrheal illness is particularly important in
developing countries, where infection with these pathogens
in children under the age of two years may lead to death
[5]. The majority of human infections are caused by C.
jejuni (80-85%), whereas most of the remaining cases are
attributed to C. coli [6]. Even though epidemiological data
fromAfrica, Asia, andMiddle East are still incomplete, avail-
able data indicate that Campylobacter infection is endemic
in these regions [2]. Poultry is the main reservoir of these
pathogens and harbors them without clinical manifestations.
Transmission of Campylobacter to humans occurs mainly
through consumption of contaminated raw/undercooked
poultry products, or through close contact with infected
animals [7, 8]. A small proportion of campylobacteriosis
cases may be attributed to other animals or environmental
sources [9]. In the EU, it has been estimated that 50 to 80%
of human cases of campylobacteriosis may be attributed to
the chicken reservoir, whereas the handling, preparation, and
consumption of contaminated broiler meat may account for
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20 to 30%of cases [10].Themajority of humanCampylobacter
infections results in a self-limiting gastroenteritis illness
and does not require specific treatment. However, severe,
prolonged or systemic infections, in immunocompromised,
vulnerable population and children may require antimicro-
bial therapy. The macrolides (erythromycin) are usually the
first-line drugs, whereas fluoroquinolones and, to a lesser
extent, tetracycline represent alternative options [11]. Not
long ago, Campylobacter has developed resistance to several
antimicrobial agents, including macrolides, tetracycline, and
quinolones [12]. Multidrug-resistant Campylobacter strains
have been frequently isolated, and this could complicate
the treatment of human infection [13]. In addition to
the campylobacteriosis morbidity and the risk to develop
long term sequelae (e.g., Guillian Barre’ syndrome (GBS)
and reactive arthritis), the development of resistance to
antimicrobial drugs by Campylobacter strains constitutes
an important concern. Thus, the development of effective
mitigation strategies for Campylobacter reduction in broiler,
as well as the successful use of antimicrobial treatment,
requires a good understanding of the epidemiological status
of Campylobacter infection in flocks, in order to decrease
the prevalence of this infection and likely antimicrobial
resistance.
The aim of the present study is to assess thermophilic
Campylobacter prevalence in broiler flocks in North East of
Tunisia and to determine antimicrobial resistance rates and
patterns of recovered Campylobacter strains.
2. Material and Methods
2.1. Sampling. Samples were collected from 13 broiler farms,
between December 2016 and May 2018, located in three
governorates including Ariana, Ben Arous, and Nabeul (in
theNorth East of Tunisia).These areas ensure 29% of national
broiler production [14]. From each farm, 30 to 50 cloacal
swabs were taken from randomly selected birds. All farms
have similar breeding and biosecurity/biosafety protocols.
2.2. Isolation of Campylobacter. Overall, 590 cloacal swabs
were taken from chickens. Samples were inoculated into
Bolton Broth (Oxoid, UK) and incubated, for enrichment,
at 42∘C for 48 h in a microaerobic environment (5% O
2
,
10% CO
2
and 85% N
2
), created by GENbox generators
(BioMerieux, France). A loopful of each enriched sample
was streaked on Karmali plates (SIGMA-ALDRICH) and
incubated under the same conditions, as described above.
From each sample, a total of ten swarming, opaque, white
to grey colonies suspected of being campylobacters were
subcultured on Karmali agar. Colonies comprising curved or
spiral motile rods, when observed by light microscopy, were
examined for oxidase/catalase activities and Gram stained.
Thereafter, a maximum of three microscopically confirmed
Campylobacter isolates per sample were subjected to PCR
analyses for genus confirmation and species identification.
Confirmed Campylobacter isolates were stored in brain
heart infusion broth (Bio-Rad) with 25% glycerol at −80∘C
for further analysis. Only one isolate per positive samples was
used for further analyses.
2.3. Molecular Identification. For PCR analysis, template
DNAs were prepared by boiling method. Presumptive
Campylobacter spp. colonies were selected from Karmali
agar and cultured in Bolton Broth for 24h, in the same
conditions as described above. A volume of 100 𝜇l of culture
was centrifuged at 13,000 × g for 10 min and the supernatant
was carefully discarded. The bacterial pellet was suspended
in 500 𝜇l of TE buffer [10 mM Tris-HCl, 1 mM EDTA (pH
8.0)] and heated by immersion in a boiling water bath for 10
min. The samples were cooled immediately on ice for 5 min
and centrifuged at 13000 × g for 5 min. The supernatant was
recovered and stored at -20∘C, until analysis.
Genus confirmation of presumed Campylobacter isolates
was performed by PCR amplification of a specific fragment of
16S rRNA gene, using previously described primers [15]. The
isolates were confirmed as C. jejuni or C. coli by PCR assays
based on mapA and CeuE genes amplification, respectively
[16, 17]. The sequence and the origin of the three sets of used
primers are indicated in Table 1.
All PCR reactions contained 2.5 𝜇l DNA template, 0.2 𝜇M
of each primer (Carthagenomics Advanced Technologies,
Tunisia), 0.2mMof dNTP (PROMEGA), 1XDreamTaqDNA
polymerase buffer, and 1.0 U of Dream Taq DNA polymerase
(Thermo Scientific), in a final reaction volume of 25 𝜇l.
The PCR protocol for genus identification was as follows:
5 minutes at 95∘C, 35 cycles consisting of 1 min at 95∘C, 1
min at 55∘C, 1 min at 72∘C, and a final extension step of
10 minutes at 72∘C. The same protocol was used for species
identification, except for annealing temperature, which was
at 59∘C. All DNA amplification reactions were carried out in
a T100 thermal cycler (BIO-RAD).
For the visualization of PCR products, 10 𝜇l was subjected
to electrophoresis on agarose gel containing ethidium bro-
mide, and bands were visualized with UV light.
C. jejuni (ATCC 33291) and C. coli (CCUG 11283-T) were
included in all tests as positive controls.
2.4. Antimicrobial Susceptibility Testing. Campylobacter iso-
lates were tested for susceptibility to antimicrobial drugs
by disk diffusion method, as recommended by the Euro-
pean Committee on Antimicrobial Susceptibility Testing
(EUCAST) [18]. Bacterial suspension of 0.5 McFerland was
prepared from 24h culture and inoculated on Mueller-
Hinton agar (Becton Dickinson) plates supplemented with
5% defibrinated sheep blood. All isolates were tested with
the following antibiotics: ampicillin (AM: 10 𝜇g), amoxi-
cillin/clavulanic acid (AMC: 20/10 𝜇g), gentamicin (GEN:
10 𝜇g), erythromicin (ERI: 15 UI), nalidixic acid (NA: 30
𝜇g), ciprofloxacin (CIP: 5 𝜇g), tetracycline (Tet: 30 𝜇g), and
chloramphinicol (CHL: 30 𝜇g). Plates were incubated at 37∘C
for 24h in microaerophilic atmosphere. C. jejuni (ATCC
33291) was used as quality control organism.
Inhibition zones were measured and interpreted as rec-
ommended by EUCAST’s criteria [18]. Isolates exhibiting
phenotypic resistance to three or more antimicrobial classes
were regarded as multidrug resistant.
2.5. Data Analysis. All the data collected within the present
study were analyzed using R software, a language and
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Table 1: Primers sequence used for Campylobacter spp. identification and expected amplicon sizes.
Species Gene Sequence (5󸀠/3󸀠) Amplicon (bp) References
C. spp rRNA GGATGACACTTTTCGGAGC-CATTGTAGCACGTGTGTC 816 Linton et al. 1996
C. jejuni mapA CTATTTTATTTTTGAGTGCTTGTGGCTTTATTTGCCATTTGTTTTATTA 589 Stucki et al. 1995
C. coli ceuE AATTGAAAATTGCTCCAACTATGTGATTTTATTATTATTTGTAGCAGCG 462 Gonzalez et al. 1997
Table 2: Percentage of resistant Campylobacter isolates.
Antimicrobial C. jejuni% (n=91)
C. coli
% (n=41)
Total
% (n=132)
Ampicillin 73.6∗ (67) 34.1 (14) 61.4 (81)
Amoxicillin/acid clavulanic 52.7 (48) 34.1 (14) 47.0 (62)
Ciprofloxacin 98.9 (90) 100 (41) 99.2 (131)
Nalidixic Acid 57.1∗ (52) 22.0 (9) 46.2 (61)
Erythromycin 100 (91) 100 (41) 100.0 (132)
Tetracycline 100 (91) 100(41) 100.0 (132)
Chloramphenicol 83.5 (76) 100 (41) 88.6 (117)
Gentamycin 14.3 (13) 9.8 (4) 12.9 (17)
∗Significantly higher resistance (P < 0.05) of C. jejuni compared with C. coli.
environment for statistical computing [19].The antimicrobial
resistance analyses were performed by means of a Chi-
square statistic (P < 0.05) [20]. This test is a nonparametric
tool designed to compare frequency counts between two
groups of different sample sizes. Comparison between isolate
prevalence across season in three Tunisian governorates was
carried out by means of a one-way analysis of variance
(ANOVA) [21], followed by a TukeyHSD test (Tukey Honest
Significant Differences). This later is a post hoc test based
on the studentized range distribution (q Statistics) [22]. The
selection criterion for significantly prevalence variance was a
stringent p value of 0.001 or less.
3. Results
3.1. Thermotolerant Campylobacter spp. Prevalence. The
present study revealed that the prevalence of Campylobacter
spp. was of 22.4% (132/590). A total of 132 isolates was
recovered from cloacal swabs, from 10 out of 13 investigated
flocks.
When looking at the distribution of Campylobacter spp.,
C. jejuniwas the prominent isolated species (68.9%), followed
by C. coli (31.1%). Five samples collected from the same farm
were found containing both C. jejuni and C. coli (0.8%).
The prevalence of infected flocks ranged from 6.1% to
56%, and the prevalence of infection per governorate ranged
from 11.1% to 54%. Regarding, the distribution of both
thermophilic species, no significant difference (P < 0.001) was
noticed regarding flocks or governorates.
On the other hand, we have shown that the highest
prevalence of Campylobacter spp. infection was found in
autumn season (52%) and the lowest during thewinter season
(3.5%). In spring and summer, we have obtained the same rate
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of infection (11%) (Figure 1). The difference between seasonal
prevalence was statistically significant (P < 0.001).
3.2. Antibiotic Susceptibility of Isolated Strains. Results of
antimicrobial susceptibility of both C. jejuni and C. coli
isolates against the eight tested antimicrobial agents are
shown in Table 2.
All isolates (100%) were resistant to tetracycline and
erythromicin, and a very high resistance was observed
against ciprofloxacin (99.2%) and chloramphenicol (88.6%).
To a lesser extent, resistance rates to 𝛽-lactams were about
4 BioMed Research International
Table 3: Multidrug resistance profiles of Campylobacter jejuni and Campylobacter coli.
Antimicrobial resistance pattern No. of AMC∗
C. jejuni
(n=91) %
C. coli
(n=41) %
No % No %
CIP ERI TET CHL 4 14 15.4% 26 63.4%
AM AMCNAL CIP ERI TET 4 2 2.2% 0 0
AMC CIP ERI TET CHL 5 2 2.2% 0 0
AMNAL CIP ERI TET 5 7 7.7% 0 0
AM CIP ERI TET CHL 5 12 13.2% 0 0
AM AMC CIP ERI TET 5 3 3.3% 0 0
AMC NAL CIP ERI TET CHL 5 6 6.6% 0 0
AMNAL CIP ERI TET GEN 5 2 2.2% 0 0
AM AMC CIP ERI TET CHL 5 0 0 5 12.2%
AM AMCNAL ERI TET CHL 5 2 2.2% 0 0
AMNAL CIP ERI TET CHL 5 4 4.4% 0 0
AM AMCNAL CIP ERI TET CHL 5 23 25.3% 5 12.2%
AM CIP ERI TET CHL GEN 6 3 3.3% 0 0
AMC CIP ERI TET CHL GEN 6 2 2.2% 0 0
AM AMC CIP ERI TET CHL GEN 6 2 2.2% 0 0
AMC NAL CIP ERI TET CHL GEN 6 2 2.2% 0 0
AM AMCNAL CIP ERI TET CHL GEN 6 5 5.5% 5 12.2%
∗AMC: antimicrobial class.
61.4% to ampicillin and 47.0% to amoxicillin/acid clavulanic.
Similar resistance levels were also observed for the nalidixic
acid (46.2%). The resistance rates between C. jejuni and C.
coli isolates against AM (73.6% and 34.1%) and NA (57.1%
and 22%, respectively) differ significantly (P < 0.05). No
significant difference was observed between both species for
the other AMD.
Multidrug resistance to three antimicrobial classes was
detected in all Campylobacter isolates and frequency of
resistance profile including 4, 5, and 6 AMC was as follows;
31.8%, 53.8%, and 14.4%, respectively.
When looking at the AMR patterns, 17 R-types were
found for all Campylobacter isolates (Table 3), with the
combination “CIP, ERI, TET, and CHL” as the most common
profile (30.3%). A significant higher percentage of C. coli
strains (63.4%) belonged to this group, compared with C.
jejuni isolates (15.4%).Thenextmost frequent pattern was the
combined resistance to “AM, AMC, NA, CIP, ERI, TET, and
CHL”, detected in 21.2% of isolates. The remaining patterns
comprised less than 10% of isolates. For C. coli, only four
patterns composed of 4, 5 (2 patterns), and 6 antimicrobial
classes were detected. One of these patterns corresponding to
“AM, AMC, CIP, ERI, TET and CHL” combination seems to
be specific to C. coli isolates (n=5; 3.8%).
4. Discussion
Poultry is the main reservoir of Campylobacter and its meat
consumption represents a major cause of human campy-
lobacteriosis. The presence of such pathogens in poultry is of
great concern for human health, and their control in broiler
flocks has a great impact on public health.
In Tunisia, as in many developing countries, there is
limited information regarding Campylobacter status in con-
ventional broiler flocks. Our findings demonstrated that the
prevalence of Campylobacter in broiler flocks was about
22.4%. This prevalence can be considered as moderate
compared to those reported by other studies in different
countries. Indeed, studies in Brazil, Costa Rica, and Sri-
Lanka showed that 100.0%, 80.0%, and 63.8%, of flocks were,
respectively, Campylobacter positive [23–25]. The European
baseline study on Campylobacter in broilers indicated that
the EU prevalence was 71.2%, ranging from 2% in Estonia
to a maximum of 100% in Luxembourg [10]. The prevalence
assessed in the present study is higher than prevalence
shown in the European Nordic countries, such as Sweden
(13%), Finland (3.9%), and Denmark (10.3%), but lower than
prevalence reported in Spain (88%), Portugal (82%), and
France (76.1%).
Regarding Campylobacter species distribution, C. jejuni
was the most common species (68.9%) found, followed by C.
coli (31.1%). These results are similar to other investigations
reporting C. jejuni and C. coli as the most frequently isolated
species in poultry [26, 27] and their distribution is compa-
rable to our results (Ireland: 68.9% and 32.4%; Austria 65.1%
and 33.3% for C. jejuni and C. coli, respectively) [10].
The prevalence of Campylobacter in positive flocks at the
governorate level ranged from 11.1% to 54%, and those within
flocks varied from 6.1% to 56%. No significant difference
was found related to region distribution, since the three
sampled governorates belong to the same geographic region
and have similar climatic conditions. Regarding the seasonal
distribution, the highest positive percentage was found in
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flocks sampled in autumn, against a lower prevalence in
winter (3.5%). Thus, we can admit that high prevalence of
Campylobacter is related to the season rather than to other
factors. In fact, in autumn the weather in Tunisia is warm
and humid and the highest Heat Index (HI) values are noted
in September and October [28]. These weather conditions
combined with the type of poultry rising (in house) seem
to be favorable for the survival of campylobacters in the
environment and to enhance their spread in flocks [25]. This
positive association is in agreement with data reported by
the literature and supported by the seasonality feature of this
disease in human, with a peak incidence always observed
during warm and humid seasons [29].
Furthermore, the moderate prevalence of Campylobac-
ter observed in our study is probably associated with the
management practices and the biosecurity measures, imple-
mented in the country to control bacterial infections (par-
ticularly Salmonella) in broiler chain production. In fact, all
farms integrated in this study are composed of conventional
broiler chicken house for intensive production, with similar
management practices.
Moreover, it was shown in several studies that the risk of
Campylobacter spread in a flock is directly related to the age of
birds, and it increases with the presence of older flocks [30].
However, in our study we have included only broiler farms
with birds aged no more than 6 weeks, which might explain,
in part, this moderate prevalence.
Additionally, the susceptibility of recovered Campy-
lobacter isolates against different antimicrobial drugs was
investigated. Our results highlighted that C. coli and C.
jejuni present high resistance rates to erythromycin, tetra-
cycline, ciprofloxacin, and chloramphenicol and lower rates
to nalidixic acid, ampicillin, amoxicillin/acid clavulanic, and
gentamicin.
These high resistance rates for ERI (100%), TET (100%),
and CIP (99.2%) are comparable to those reported in Italy
[25, 31] and can be explained by the common use of the
same antimicrobials as first-line drugs in broiler farms to
combat bacterial infections. In fact, studies have shown clear
positive association between the use of fluoroquinolones in
poultry production and a resistance increase of Campylobac-
ter isolates from chicken and human origins [32]. Whereas
in countries not permitting the use of fluoroquinolones
in poultry production, such as Australia and the Nordic
European countries, few resistant Campylobacter isolates
were found in chickens and humans [33]. Taken together, the
high levels of antibiotic resistance are obviously related to the
irrational and uncontrolled use of antimicrobial drugs.
On the other hand, the low antimicrobial resistance rate
to gentamicin (12.9%) might be due to the infrequent usage
of this antibiotic in poultry production because of its high
cost. At a second level, the resistance to 𝛽-lactams (61.4%
and 47.0%) can be considered as moderate and these results
could reflect national initiatives to fight the misuse of such
antibiotics. In fact, because of the high resistance levels
to these antimicrobial drugs during the last few years in
humans, their administration was considerably reduced. The
decreased use of these AMD could likely influence positively
their efficacy when used again.
When looking at the resistance rates within species,
we have noted a significant difference to the AM and the
NA between C. jejuni and C. coli; nevertheless, the rela-
tionship between species and resistance pattern is not yet
clear.
All Campylobacter isolates were identified as MDR, and
combined patterns comprising more than three AMC were
found in all isolates. Such alarming resistance rates were
reported in several countries, like Algeria (100%) [34], Italy
(100%) [35], China (86%), and Pakistan (90.4%) [36].
In addition to our findings, multiple studies have shown
that AMR is a significant problem in Tunisia [37], and this
worrisome phenomenon is worsen by the lack of national
antimicrobial surveillance systems. Nevertheless, national
health authorities and experts (clinicians, epidemiologists,
microbiologists. . .) are fully aware of the magnitude of this
issue. Thus several efforts based mainly on an education
strategy and on the restriction of the availability of selected
antimicrobial agents, to streamline their use in husbandry
and in public health, have been supported to be implemented
in the country.
5. Conclusions
The current study provides data on the occurrence of Campy-
lobacter infection in broiler flocks and the antibiotic resis-
tance, in Tunisia.The high resistance rates and the emergence
of multidrug resistant strains to several antimicrobial classes
are alarming. Therefore, the implementation of specific con-
trol procedures for AMR surveillance and the adoption of a
One Health approach are becoming mandatory, to prevent
the emergence and the spread of resistant Campylobacter
strains.
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